首页> 外国专利> MIRNA AND ITS TARGETS RESPECTIVELY THE PROTEINS MADE BASED ON THE TARGETS AS A PROGNOSTIC, DIAGNOSTIC BIOMARKER AND THERAPEUTIC AGENT FOR CANCER

MIRNA AND ITS TARGETS RESPECTIVELY THE PROTEINS MADE BASED ON THE TARGETS AS A PROGNOSTIC, DIAGNOSTIC BIOMARKER AND THERAPEUTIC AGENT FOR CANCER

机译:MIRNA及其靶标分别基于作为靶标,诊断性生物标志物和癌症治疗剂的靶标制成的蛋白质

摘要

A compound miRNA (miRNA661) (Nr MI0003669 or ENSG00000207574) the sequence of the mature miRNA-661 being 51-ugccugggucucuggccugcgcgu-74 for use as a medicament in the in the treatment and/or the diagnosis of cancer, neuronal disease and infection.
机译:化合物miRNA(miRNA661)(Nr MI0003669或ENSG00000207574)成熟的miRNA-661的序列为51-ugccugggucucuggccugcgcgu-74,用作治疗和/或诊断癌症,神经元疾病和感染的药物。

著录项

  • 公开/公告号US2012115928A1

    专利类型

  • 公开/公告日2012-05-10

    原文格式PDF

  • 申请/专利权人 GUILLAUME VETTER;EVELYNE FRIEDERICH;

    申请/专利号US201013260488

  • 发明设计人 GUILLAUME VETTER;EVELYNE FRIEDERICH;

    申请日2010-03-26

  • 分类号A61K31/7088;A61P25;G01N33/574;A61P35;C07H21/02;C07K14/47;

  • 国家 US

  • 入库时间 2022-08-21 17:29:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号